Biosantech

BIOSANTECHBIOSANTECH, founded by Roger and Corinne TREGER in April 2011, is an innovative start-up located in Sophia Antipolis Valbonne, in the Provence-Alpes-Côte d'Azur region. BIOSANTECH aims to develop an effective therapeutic vaccine targeting all variants of the HIV virus from the active ingredient TAT oyi. BIOSANTECH has an exclusive agreement with CNRS and Aix Marseille University. BIOSANTECH has been granted an exclusive license for the enhancement and commercialization of the CNRS patent related to TAT oyi. To date, the therapeutic vaccine has shown the best results in maintaining viral load rebound two months after stopping triple therapy. It also places patients in undetectable DNA levels for at least two years.The publication of clinical trial results in retrovirology demonstrates very encouraging efficacy in achieving functional cures for AIDS patients.